Generation of a human induced pluripotent stem cell line (CPGHi003-A) from an auditory neuropathy patient with AIFM1 p.R422Q mutation

Stem Cell Res. 2021 May:53:102376. doi: 10.1016/j.scr.2021.102376. Epub 2021 Apr 29.

Abstract

AIFM1 is the most common gene related to late-onset Auditory Neuropathy (AN), which is characterized by a main manifestation of impaired speech comprehension. By using a nonintegrating plasmid delivery system, we generated induced pluripotent stem cells (iPSCs) from the peripheral blood cells of a male patient from the family carrying the X-linked AIFM1 p.R422Q mutation. The resulting iPSCs had a normal karyotype, showed pluripotency by immunofluorescence staining, and differentiated into the three germ layers in vitro. This cellular model will provide a useful platform for investigating the pathogenic mechanisms of AIFM1-related AN, further laying the foundation for clinical treatment in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis Inducing Factor
  • Cell Differentiation
  • Hearing Loss, Central
  • Humans
  • Induced Pluripotent Stem Cells*
  • Male
  • Mutation

Substances

  • AIFM1 protein, human
  • Apoptosis Inducing Factor

Supplementary concepts

  • Auditory neuropathy